Advisors Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Advisors Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,979	Closed	-$107K	–	1565
2017 Q4	$107K	Sell	1,979 -425	-18%	-$23.3K	﹤0.01%	1327
2017 Q3	$137K	Sell	2,404 -431	-15%	-$25.2K	﹤0.01%	1300
2017 Q2	$171K	Sell	2,835 -677	-19%	-$38.6K	﹤0.01%	1296
2017 Q1	$191K	Buy	+3,512	New	+$173K	﹤0.01%	1305

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Advisors Asset Management's BIVV Position: Q1 2018 in Review

Advisors Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,979 shares — an estimated $107K sold.

Advisors Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $191K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Advisors Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Advisors Asset Management sold 1,979 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $107K.
Advisors Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Advisors Asset Management's Bioverativ Inc. Common Stock position peaked at $191K in Q1 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Advisors Asset Management's 13F filing for Q1 2018, filed 15 May 2018.